Cite
Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome.
MLA
Marie-Cardine, Anne, et al. “Killer Cell Ig-like Receptors CD158a and CD158b Display a Coactivatory Function, Involving the c-Jun NH2-Terminal Protein Kinase Signaling Pathway, When Expressed on Malignant CD4+ T Cells from a Patient with Sezary Syndrome.” Blood, vol. 109, no. 11, June 2007, pp. 5064–65. EBSCOhost, https://doi.org/10.1182/blood-2007-02-071993.
APA
Marie-Cardine, A., Huet, D., Ortonne, N., Remtoula, N., Le Gouvello, S., Bagot, M., & Bensussan, A. (2007). Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome. Blood, 109(11), 5064–5065. https://doi.org/10.1182/blood-2007-02-071993
Chicago
Marie-Cardine, Anne, Delphine Huet, Nicolas Ortonne, Natacha Remtoula, Sabine Le Gouvello, Martine Bagot, and Armand Bensussan. 2007. “Killer Cell Ig-like Receptors CD158a and CD158b Display a Coactivatory Function, Involving the c-Jun NH2-Terminal Protein Kinase Signaling Pathway, When Expressed on Malignant CD4+ T Cells from a Patient with Sezary Syndrome.” Blood 109 (11): 5064–65. doi:10.1182/blood-2007-02-071993.